Q-omics provides the consensus-scored COX6CP4 profile across patient tissues and cancer cell-line models. COX6CP4 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in COAD. Additionally, COX6CP4 RNA expression shows 4,824 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight COAD, and STAD as cancer lineages where COX6CP4 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.